Viridos
Doug Miller is currently the Chief Financial Officer at Viridos. Prior to this position, Doug held various finance and accounting roles at companies such as Halozyme Therapeutics, Inc., CareFusion, and PricewaterhouseCoopers. With a background in M&A, integration, separation, and accounting consulting, Doug has a strong foundation in finance. Doug holds a Bachelor's degree in Government from Wesleyan University and a Master of Business Administration from Questrom School of Business, Boston University.
Viridos
Viridos is a privately held biotechnology company harnessing the power of photosynthesis to create transformative solutions to mitigate climate change. Our unparalleled understanding of algal genetics and ability to translate innovation from lab to field underpins our initial deployment: a scalable platform to produce low-carbon intensity biofuels for aviation, commercial trucking, and maritime shipping. Building on a legacy of genomic firsts, our team of scientists and engineers are shaping new pathways toward a sustainable bioeconomy. To learn more, visit us at Viridos.com.